Polymyositis associated with simvastatin

Lancet

Volumn 349, Issue 9065, 1997, Pages 1600-1601

  Giordano, Nicola ^a   Senesi, Marco ^b   Mattii, Giancado ^b   Battisti, Emilio ^b   Villanova, Marcello ^b   Gennari, Carlo ^b  

^a UNIVERSITY OF SIENA   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTILIPEMIC AGENT; ATENOLOL; CREATINE KINASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METHYLPREDNISOLONE; SIMVASTATIN;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; CREATINE KINASE BLOOD LEVEL; DRUG WITHDRAWAL; ELECTROMYOGRAPHY; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; MALE; MUSCLE BIOPSY; MYOPATHY; POLYMYOSITIS; PRIORITY JOURNAL; REMISSION;

EID: 0030988691     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)61628-5     Document Type: Article

References (5)

1. Dalakas MC. Inflammatory and toxic myopathies. Curr Opin Neurol Neurosurg 1992; 5: 645-54.
2. Pierce IR, Wysowski DK, Gross TP, et al. Myopathy and rhabdomyolysis associated with lovastatin-gemfibrozil combination therapy. JAMA 1990; 4: 71-75.
3. Sauvaget F, Piette JC, Herson S, et al. Fenolibrate-induced polymyositis. Rev Med Intern 1991; 12: 52-54.
4. Le Quintrec JS, Quintrec JL. Drug-induced myopathies. Bailleres Clin Rheumatol 1991; 5: 21-38.
5. Zuckner J, Drug-induced myopathies. Semin Arthritis Rheum 1990; 19: 259-64.